Authors:
TORMANS G
VANDOORSLAER E
VANDAMME P
CLARA R
SCHMITT HJ
Citation: G. Tormans et al., ECONOMIC-EVALUATION OF PERTUSSIS PREVENTION BY WHOLE-CELL AND ACELLULAR VACCINE IN GERMANY, European journal of pediatrics, 157(5), 1998, pp. 395-401
Authors:
VANDOORSLAER EKA
TORMANS G
GUPTA AK
VANROSSEM K
EGGLESTON A
DUBOIS DJ
DEDONCKER P
HANEKE E
Citation: Eka. Vandoorslaer et al., ECONOMIC-EVALUATION OF ANTIFUNGAL AGENTS IN THE TREATMENT OF TOENAIL ONYCHOMYCOSIS IN GERMANY, Dermatology, 193(3), 1996, pp. 239-244
Authors:
BEUTELS P
CLARA R
TORMANS G
VANDOORSLAER E
VANDAMME P
Citation: P. Beutels et al., COSTS AND BENEFITS OF ROUTINE VARICELLA VACCINATION IN GERMAN CHILDREN, The Journal of infectious diseases, 174, 1996, pp. 335-341
Authors:
BOOGAERTS M
TORMANS G
MAES E
VANDOORSLAER B
Citation: M. Boogaerts et al., COST-EFFECTIVENESS ANALYSIS OF AMBISOME (AMB) VS AMPHOTERICIN-B (AMPHOB) IN THE EMPIRIC TREATMENT OF FEBRILE NEUTROPENIA IN ADULTS AND CHILDREN, Blood, 88(10), 1996, pp. 1994-1994
Citation: E. Vandoorslaer et al., COST-EFFECTIVENESS ANALYSIS OF VACCINATION AGAINST HEPATITIS-A IN TRAVELERS, Journal of medical virology, 44(4), 1994, pp. 463-469
Authors:
VLIETINCK R
VANLOON H
VANDEBROELE H
TORMANS G
Citation: R. Vlietinck et al., RETROSPECTIVE ESTIMATE OF THE NURSING COST OF AUTONOMY IMPAIRMENT ANDCOST-BENEFIT IN CLINICAL-TRIALS - FEASIBILITY AND APPLICATION OF PIRACETAM IN DEMENTED ELDERLY PATIENTS, Advances in therapy, 10(5), 1993, pp. 226-244
Authors:
TORMANS G
VANDAMME P
CARRIN G
CLARA R
EYLENBOSCH W
Citation: G. Tormans et al., COST-EFFECTIVENESS ANALYSIS OF PRENATAL SCREENING AND VACCINATION AGAINST HEPATITIS-B VIRUS - THE CASE OF BELGIUM, Social science & medicine, 37(2), 1993, pp. 173-181